Jia Wei

25PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 28, 2026
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis.

|Jul 07, 2026
Optimizing Postoperative Management in Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Gastroesophageal Junction Adenocarcinoma: A Multicenter Retrospective Study.

|Jun 23, 2026
Efficacy and safety of infigratinib in patients with refractory advanced gastric or gastroesophageal junction adenocarcinoma harboring FGFR2 gene amplification: a single-arm, multicenter phase 2 trial.

|Mar 02, 2026
Dynamic reprogramming of the tumor immune network via multicycle checkpoint degradation for cancer immunotherapy.

Tao Shi, Yuanyuan Wu, Yiran Cai

|Dec 16, 2025
From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity.

Tao Shi, Yiran Cai, Hanbing Wang

|Mar 27, 2025
Author Correction: First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial.

Lin Shen, Yanqiao Zhang, Ziyu Li

Pageof 5

Frequent Collaborators

6 joint publications

Tao Shi

6 joint publications

Baorui Liu

4 joint publications

Ju Yang

3 joint publications

Lin Shen